Apixaban (Eliquis) prior authorization at Elevance Health
Submission criteria, P2P prep, and appeal path if denied — for prescribers and PA staff
Elevance Health requires prior-authorization documentation for Apixaban (Eliquis): a diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. Standard PA decisions return in 30 days; if denied, prescribers and members have 180 days to appeal.
The PA criteria you'll need to meet
Elevance Health reviews Apixaban (Eliquis) prior authorizations against its medical policy . Elevance Health-specific context: Operates Anthem BCBS in 14 states. Owns Carelon (formerly AIM) which manages utilization for specialty drugs and advanced imaging. State complaint route is to the state insurance department where the policy was issued.
Documentation packet checklist
- Chart note with diagnosis (ICD-10 code) and clinical severity markers
- Documented failure of, contraindication to, or intolerance of step-therapy alternatives in this class
- Prior treatment history including dosing, duration, and reason for discontinuation
- Relevant labs, imaging, or assessment scores supporting medical necessity
- Prescriber attestation linking the FDA-approved indication to the patient's presentation
- Elevance Health's medical policy URL referenced in the cover letter
Elevance Health's common denial patterns
Pre-empting these patterns in the initial submission cuts rework and shortens time-to-approval:
- Step therapy
- Medical necessity for biologics
- Out-of-network for behavioral health
- Bariatric surgery prior auth
Apixaban (Eliquis)-specific denial patterns and context
Across payers (not just Elevance Health), Apixaban (Eliquis)draws a distinct set of denial reasons rooted in the drug's label, REMS, and competitive landscape:
- Step therapy requiring warfarin first
- Non-formulary
Brand: Eliquis. Most-prescribed DOAC. Pre-MFN price negotiations apply.
Manufacturer patient-assistance program: Eliquis Free 30-Day Trial — relevant when an Elevance Health denial sticks and the patient needs bridge access while appealing.
How Elevance Health approaches Direct oral anticoagulants (DOACs) PAs
Elevance Health's Direct oral anticoagulants (DOACs) reviewer typically anchors Apixaban prior-auth decisions on step therapy. Pharmacy-benefit review for Apixaban at Elevance Health is routed through CarelonRx (utilization management via Carelon, formerly AIM Specialty Health). The 30-day standard review window starts when the prior-authorization request is received with all required documentation — incomplete packets pause the clock and add 5-10 days to time-to-approval, after which the 180-day internal-appeal window begins from the denial date. Elevance Health's warfarin-step-first policy is defensible only when the patient lacks documented intolerance, labile INR, drug-interaction risk, or non-valvular AF with stroke risk — citing AHA/ACC/HRS 2023 typically overturns. Elevance Health is domiciled in IN, so unresolved appeals escalate to the IN insurance department's external-review program for fully-insured policies (self-funded ERISA plans route to the DOL EBSA instead). Operates Anthem BCBS in 14 states.
If the PA is denied
Elevance Health gives prescribers and members 180 days to file an internal appeal. Standard appeal decisions return within 30 days. Submit through the provider portal (https://providers.anthem.com) with the same packet plus a peer-reviewed citation supporting Apixaban (Eliquis)for the patient's indication.
Helping a patient appeal the denial directly? See the consumer guide: How to appeal an Elevance Health denial on DenialHelp.
Contact Elevance Health
- Provider portal: https://providers.anthem.com
Frequently asked questions
What documentation does Elevance Health need for Apixaban (Eliquis) prior auth?
Elevance Health's typical PA packet for Apixaban (Eliquis): (1) chart note documenting the indication and prior-treatment failures, (2) supporting lab/imaging where indicated, (3) prescriber attestation that step-therapy alternatives were tried or contraindicated, (4) FDA-approved indication mapped to ICD-10 diagnosis.
What's the turnaround time at Elevance Health?
Standard Apixaban (Eliquis) PA decisions at Elevance Health: 30 days. Urgent / expedited (member's life or function at risk): 72 hours under 45 CFR §147.136.
What does Elevance Health most often reject Apixaban (Eliquis) for?
Across Elevance Health's book the common rejection patterns include: Step therapy; Medical necessity for biologics; Out-of-network for behavioral health. For Apixaban (Eliquis) specifically, expect step-therapy challenges and indication-restriction reviews when the use is at the edge of the FDA label or off-label.
Will Elevance Health accept a contraindication to warfarin instead of a warfarin trial for Apixaban?
Yes — Elevance Health accepts documented warfarin contraindication or intolerance in place of a warfarin trial. Acceptable contraindications include labile INR (TTR <60% on prior warfarin), high bleeding risk (HAS-BLED ≥3), drug-interaction burden, valvular AF (which actually mandates warfarin, not contraindicates), or patient inability to comply with INR monitoring. Cite AHA/ACC/HRS 2023 AF Guideline language for the DOAC-first rationale in non-valvular AF. Pharmacy-benefit handling is routed through CarelonRx (utilization management via Carelon, formerly AIM Specialty Health). External-review escalation for Elevance Health fully-insured policies sits with the IN insurance department.
How do I prep for a peer-to-peer with Elevance Health on Apixaban (Eliquis)?
Lead with the FDA-approved indication and the specific clinical criteria the policy lists. Have the patient's chart open, document number, and policy URL on screen. State your name and credentials, the policy number, the indication, and the documented failures of step-therapy alternatives. Keep notes — if the P2P reviewer overturns, get the decision in writing.
Related PA criteria
Generate the Apixaban (Eliquis) PA packet
Open ApprovalHelp — generate a Apixaban (Eliquis) prior-auth packet tailored to Elevance Health's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com